Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 1, 2025 • 12:21 PM ET

Date/Time Source News Release
03/31/2025 02:14 PM EDT GlobeNewswire Actinium Pharmaceuticals, Inc. Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Against ATNM
03/31/2025 01:00 PM EDT GlobeNewswire ROSEN, A TOP RANKED LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
03/30/2025 09:18 AM EDT Newsfile ROSEN, A LONGSTANDING LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
03/29/2025 01:15 PM EDT PR Newswire ATNM Investors Have Opportunity to Lead ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit
03/29/2025 08:16 AM EDT Newsfile ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
03/28/2025 05:19 PM EDT Business Wire Rosen Law Firm Urges Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
03/28/2025 05:09 PM EDT GlobeNewswire ROSEN, A LEADING LAW FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
03/28/2025 04:53 PM EDT Business Wire Securities Fraud Investigation Into Actinium Pharmaceuticals, Inc. (ATNM) Announced - Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
03/28/2025 11:57 AM EDT GlobeNewswire Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Actinium Pharmaceuticals, Inc. (ATNM)
03/27/2025 10:00 PM EDT Business Wire ATNM Investors Have Opportunity to Lead Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Page

Additional News

As of April 1, 2025 • 12:21 PM ET

Date/Time Source News Release
03/31/2025 05:00 PM EDT ACCESS Newswire IA ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
03/30/2025 04:03 PM EDT ACCESS Newswire IA ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
03/27/2025 08:30 AM EDT Financial News Media Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements
03/26/2025 09:59 AM EDT SeekingAlpha Actinium rises ahead of presentation at Trump Mar-a-Lago Club
12/11/2024 09:32 AM EST SeekingAlpha My Top 2 Stock Picks For A 2025 Rebound
11/18/2024 08:05 AM EST SeekingAlpha Actinium Pharmaceuticals reports Q3 results
10/31/2024 09:37 AM EDT Zacks Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View
10/31/2024 09:32 AM EDT Zacks Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
10/18/2024 12:00 PM EDT Zacks All You Need to Know About Actinium (ATNM) Rating Upgrade to Strong Buy
09/21/2024 11:00 AM EDT ACCESSWIRE IA Actinium Pharmaceuticals, Inc. May Have Violated Securities Laws And The Schall Law Firm Encourages Impacted Shareholders To Reach Out
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.